Changes in the content of estrogen α and progesterone receptors during differentiation of mouse embryonic stem cells to dopamine neurons

Brain Research Bulletin

Volumn 73, Issue 1-3, 2007, Pages 75-80

  Díaz, Néstor F ^a   Guerra Arraiza, Christian ^a   Díaz Martínez, Néstor E ^a   Salazar, Patricia ^a   Molina Hernández, Anayansi ^a   Camacho Arroyo, Ignacio ^a   Velasco, Ivan ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Estradiol; Graft; Nestin; Oct 4; Sex hormone receptors; Tyrosine hydroxylase

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYONIC STEM CELL; FEMALE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSONISM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; DENSITOMETRY; DOPAMINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMBRYONIC STEM CELLS; ESTROGEN RECEPTOR ALPHA; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, CONFOCAL; NERVE TISSUE PROTEINS; NEURONS; OCTAMER TRANSCRIPTION FACTOR-3; OXIDOPAMINE; PREGNANCY; RECEPTORS, PROGESTERONE; STEM CELL TRANSPLANTATION; TYROSINE 3-MONOOXYGENASE;

EID: 34248178541     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.02.002     Document Type: Article

References (39)

1. Arenas E. Stem cells in the treatment of Parkinson's disease. Brain Res. Bull. 57 (2002) 795-808
2. Baldereschi M., Di Carlo A., Rocca W.A., Vanni P., Maggi S., Perissinotto E., Grigoletto F., Amaducci L., Inzitari D., and ILSA Working Group. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Italian longitudinal study on aging. Neurology 55 (2000) 1358-1363
3. Barberi T., Klivenyi P., Calingasan N.Y., Lee H., Kawamata H., Loonam K., Perrier A.L., Bruses J., Rubio M.E., Topf N., Tabar V., Harrison N.L., Beal M.F., Moore M.A., and Studer L. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 21 (2003) 1200-1207
4. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64 (1999) 803-812
5. Brannvall K., Korhonen L., and Lindholm D. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol. Cell Neurosci. 21 (2002) 512-520
6. Callier S., Morissette M., Grandbois M., Pelaprat D., and Di Paolo T. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse 41 (2001) 131-138
7. Camacho-Arroyo I., Neri-Gomez T., Gonzalez-Arenas A., and Guerra-Araiza C. Changes in the content of steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid hormone receptors in the rat brain during the estrous cycle. J. Steroid Biochem. Mol. Biol. 94 (2005) 267-272
8. Di Paolo T., Falardeau P., and Morissette M. Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle. Life Sci. 43 (1988) 665-672
9. Dluzen D. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res. 767 (1997) 340-344
10. Dluzen D.E., and McDermott J.L. Estrogen anti-estrogen, and gender: differences in methamphetamine neurotoxicity. Ann. N. Y. Acad. Sci. 965 (2002) 136-156
11. Dluzen D.E., and Ramirez V.D. In vitro progesterone modulation of amphetamine-stimulated dopamine release from the corpus striatum of ovariectomized estrogen-treated female rats: response characteristics. Brain Res. 517 (1990) 117-122
12. Edwards D.P. Regulation of signal transduction pathways by estrogen and progesterone. Annu. Rev. Physiol. 67 (2005) 335-376
13. Gonzalez-Aguero G., Ondarza R., Gamboa-Dominguez A., Cerbon M.A., and Camacho-Arroyo I. Progesterone receptor isoforms expression pattern in human astrocytomas. Brain Res. Bull. 56 (2001) 43-48
14. Graham J.D., and Clarke C.L. Physiological action of progesterone in target tissues. Endocr. Rev. 18 (1997) 502-519
15. Guerra-Araiza C., Villamar-Cruz O., Gonzalez-Arenas A., Chavira R., and Camacho-Arroyo I. Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments. J. Neuroendocrinol. 15 (2003) 984-990
16. Han H.J., Heo J.S., and Lee Y.J. Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes. Am. J. Physiol. Cell. Physiol. 290 (2006) C1067-C1075
17. Hong S.H., Nah H.Y., Lee Y.J., Lee J.W., Park J.H., Kim S.J., Lee J.B., Yoon H.S., and Kim C.H. Expression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodies. Mol. Cells 18 (2004) 320-325
18. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sanchez-Pernaute R., Bankiewicz K., and McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
19. Kipp M., Karakaya S., Pawlak J., Araujo-Wright G., Arnold S., and Beyer C. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors. Front Neuroendocrinol. 27 (2006) 376-390
20. Kishi Y., Takahashi J., Koyanagi M., Morizane A., Okamoto Y., Horiguchi S., Tashiro K., Honjo T., Fujii S., and Hashimoto N. Estrogen promotes differentiation and survival of dopaminergic neurons derived from human neural stem cells. J. Neurosci. Res. 79 (2005) 279-286
21. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., and McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18 (2000) 675-679
22. Mani S.K. Signaling mechanisms in progesterone-neurotransmitter interactions. Neuroscience. 138 (2006) 773-781
23. McKay R. Stem cells-hype and hope. Nature 406 (2000) 361-364
24. Murashov A.K., Pak E.S., Hendricks W.A., and Tatko L.M. 17beta-Estradiol enhances neuronal differentiation of mouse embryonic stem cells. FEBS Lett. 569 (2004) 165-168
25. Nagy A., Rossant J., Nagy R., Abramow-Newerly W., and Roder J.C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90 (1993) 8424-8428
26. Olesen K.M., Jessen H.M., Auger C.J., and Auger A.P. Dopaminergic activation of estrogen receptors in neonatal brain alters progestin receptor expression and juvenile social play behavior. Endocrinology 146 (2005) 3705-3712
27. Petitclerc M., Bedard P.J., and Di Paolo T. Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (1995) 491-497
28. Robinson T.E., Becker J.B., and Ramirez V.D. Sex differences in amphetamine-elicited rotational behavior and the lateralization of striatal dopamine in rats. Brain Res. Bull. 5 (1980) 539-545
29. Rodriguez-Gomez J.A., Lu J.Q., Velasco I., Rivera S., Zoghbi S.S., Liow J.S., Musachio J.L., Chin F.T., Toyama H., Seidel J., Green M.V., Thanos P.K., Ichise M., Pike V.W., Innis R.B., and McKay R.D. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson's disease. Stem Cells 25 (2007) 918-928
30. Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?. Endocrine 21 (2003) 81-87
31. Sauter C.N., McDermid R.L., Weinberg A.L., Greco T.L., Xu X., Murdoch F.E., and Fritsch M.K. Differentiation of murine embryonic stem cells induces progesterone receptor gene expression. Exp. Cell Res. 311 (2005) 251-264
32. Shim J.W., Koh H.C., Chang M.Y., Roh E., Choi C.Y., Oh Y.J., Son H., Lee Y.S., Studer L., and Lee S.H. Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL. J. Neurosci. 24 (2004) 843-852
33. Sonntag K.C., Simantov R., Kim K.S., and Isacson O. Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation. Eur. J. Neurosci. 19 (2004) 1141-1152
34. Tamas A., Lubics A., Lengvari I., and Reglodi D. Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease. Endocrine 29 (2006) 275-287
35. Van Hartesveldt C., and Joyce J.N. Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10 (1986) 1-14
36. Velasco I., Velasco-Velazquez M.A., Salazar P., Lajud N., and Tapia R. Influence of serum-free medium on the expression of glutamate transporters and the susceptibility to glutamate toxicity in cultured cortical neurons. J. Neurosci. Res. 71 (2003) 811-818
37. Villamar-Cruz O., Manjarrez-Marmolejo J., Alvarado R., and Camacho-Arroyo I. Regulation of the content of progesterone and estrogen receptors, and their cofactors SRC-1 and SMRT by the 26S proteasome in the rat brain during the estrous cycle. Brain Res. Bull. 69 (2006) 276-281
38. Woolley S.C., O'Malley B., Lydon J., and Crews D. Genotype differences in behavior and tyrosine hydroxylase expression between wild-type and progesterone receptor knockout mice. Behav. Brain Res. 167 (2006) 197-204
39. Yu L., and Liao P.C. Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice. J. Neural Transm. 107 (2000) 1139-1147